File size: 94,709 Bytes
96ee9fd |
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 |
PATIENT_ID START_DATE STOP_DATE EVENT_TYPE TREATMENT_TYPE TREATMENT_SUBTYPE AGENT NUMBER_OF_CYCLES PRESCRIBED_DOSE PRESCRIBED_DOSE_UNITS REGIMEN_NUMBER REGIMEN_INDICATION REGIMEN_INDICATION_NOTES MEASURE_OF_RESPONSE CLINICAL_TRIAL_DRUG_CLASSIFICATION ROUTE_OF_ADMINISTRATION ROUTE_OF_ADMINISTRATION-2 THERAPY_ONGOING TOTAL_DOSE TOTAL_DOSE_UNITS TX_ON_CLINICAL_TRIAL ANATOMIC_TREATMENT_SITE COURSE_NUMBER NUMBER_OF_FRACTIONS RADIATION_DOSAGE RADIATION_TREATMENT_ONGOING RADIATION_TYPE RADIATION_UNITS PHARM_REGIMEN STEM_CELL_TRANSPLANTATION STEM_CELL_TRANSPLANTATION_TYPE TCGA-BA-4074 45 97 Treatment Chemotherapy Carboplatin 1 Adjuvant No TCGA-BA-4074 425 431 Treatment Radiation Therapy Radiation 1 Palliative 2 5 2000 No cgy TCGA-BA-4074 45 97 Treatment Radiation Therapy Radiation 2 Adjuvant Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-BA-4076 18 64 Treatment Chemotherapy Fluorouracil 2 1 Adjuvant No TCGA-BA-4076 18 64 Treatment Chemotherapy Cisplatin 2 1 Adjuvant No TCGA-BA-4076 18 64 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 6800 No cgy TCGA-BA-4078 51 95 Treatment Radiation Therapy Radiation 1 Adjuvant 1 No TCGA-BA-5149 59 80 Treatment Chemotherapy Cisplatin 2 100 mg/m2 1 Adjuvant No TCGA-BA-5149 59 102 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 6000 No External Beam cgy TCGA-BA-5151 55 69 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 6600 No External Beam cgy TCGA-BA-5153 41 91 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 No TCGA-BA-5557 67 109 Treatment Chemotherapy Cisplatin 6 30 mg/m2 1 Adjuvant No TCGA-BA-5557 67 109 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-BA-5558 78 140 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 6480 No External Beam cgy TCGA-BA-6868 13 48 Treatment Chemotherapy Carboplatin 6 2248 mg 1 Adjuvant IV No 1746 mg TCGA-BA-6868 13 13 Treatment Chemotherapy Cetuximab 1 692 mg 1 Adjuvant IV No 519 mg TCGA-BA-6868 69 118 Treatment Chemotherapy Cisplatin 3 540 mg 2 Adjuvant IV No 515 mg TCGA-BA-6868 14 48 Treatment Chemotherapy Paclitaxel 6 1831 mg 1 Adjuvant IV No 1419 mg TCGA-BA-6868 70 121 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 35 7000 No External Beam cgy TCGA-BA-6869 96 137 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-BA-6870 60 152 Treatment Chemotherapy Cisplatin 1 Adjuvant No TCGA-BA-6870 76 144 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 33 6996 No External Beam cgy TCGA-BA-6873 72 118 Treatment Chemotherapy Cisplatin 3 100 mg/m2 1 Progression IV No 640 mg TCGA-BA-6873 72 122 Treatment Radiation Therapy Radiation 1 Progression Local Recurrence 1 4600 No External Beam cgy TCGA-BA-7269 67 118 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-BA-A4IF 25 53 Treatment Chemotherapy Cisplatin complete response No Yes TCGA-BA-A4IF 33 75 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 7000 No External cgy TCGA-BA-A4IG 79 140 Treatment Chemotherapy Cetuximab complete response No No TCGA-BA-A4IG 86 132 Treatment Radiation Therapy Radiation 1 complete response Regional Site 30 6000 No External cgy TCGA-BA-A4IH 87 129 Treatment Chemotherapy Cisplatin complete response No No TCGA-BA-A4IH 88 136 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-BA-A6D8 112 154 Treatment Chemotherapy Cisplatin complete response No No TCGA-BA-A6D8 107 154 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-BA-A6D8 107 154 Treatment Radiation Therapy Radiation 2 complete response Regional Site 33 5610 No External cgy TCGA-BA-A6DA 68 110 Treatment Chemotherapy Cisplatin complete response No No TCGA-BA-A6DA 68 112 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-BA-A6DD 96 163 Treatment Chemotherapy Cisplatin clinical progressive disease No No TCGA-BA-A6DD 89 133 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 19 3800 No External cgy TCGA-BA-A6DF 44 92 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 32 6400 No External cgy TCGA-BA-A6DG 58 61 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 2 400 No External cgy TCGA-BA-A6DI 18 53 Treatment Chemotherapy Cisplatin complete response No No TCGA-BA-A6DI 18 62 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 32 6400 No External cgy TCGA-BA-A6DJ 105 140 Treatment Chemotherapy Cisplatin complete response No No TCGA-BA-A6DJ 104 160 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-BA-A6DJ 104 160 Treatment Radiation Therapy Radiation 2 complete response Regional Site 30 6000 No External cgy TCGA-BA-A6DL 21 56 Treatment Chemotherapy Carboplatin complete response No Yes TCGA-BA-A6DL 21 56 Treatment Chemotherapy Paclitaxel complete response No Yes TCGA-BA-A6DL 21 56 Treatment Chemotherapy Lapatinib complete response No Yes TCGA-BA-A8YP 39 100 Treatment Chemotherapy complete response No No TCGA-BA-A8YP 49 102 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 31 6200 No External cgy TCGA-BB-4217 115 121 Treatment Radiation Therapy Radiation 1 Adjuvant 1 No TCGA-BB-4223 98 140 Treatment Chemotherapy Cisplatin 6 100 mg/m2 1 Adjuvant IV No 600 mg/m2 TCGA-BB-4223 94 135 Treatment Radiation Therapy Radiation 1 Adjuvant Regional Site 1 6000 No External Beam cgy TCGA-BB-4223 136 140 Treatment Radiation Therapy Radiation 2 Adjuvant Primary Tumor Field 2 600 No External Beam cgy TCGA-BB-4224 182 202 Treatment Chemotherapy Cisplatin 2 75 mg/m2 1 Palliative IV No 150 mg/m2 TCGA-BB-4224 229 243 Treatment Chemotherapy Gemcitabine 2 mg/m2 2 Palliative IV No mg/m2 TCGA-BB-4224 2786 2799 Treatment Chemotherapy Oxaliplatin 2 mg/m2 2 Palliative IV No mg/m2 TCGA-BB-4224 182 202 Treatment Chemotherapy Docetaxel 2 75 mg/m2 1 Palliative IV No 150 mg/m2 TCGA-BB-4224 30 69 Treatment Radiation Therapy Radiation 1 Regional Site 5580 No External Beam cgy TCGA-BB-4228 26 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 1 600 No cgy TCGA-BB-7861 43 71 Treatment Chemotherapy complete response No No TCGA-BB-7861 43 71 Treatment Radiation Therapy Radiation 1 complete response No TCGA-BB-7862 92 145 Treatment Radiation Therapy Radiation 1 complete response No TCGA-BB-7864 136 179 Treatment Chemotherapy Cisplatin complete response No No TCGA-BB-7864 136 179 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000.00 No External cgy TCGA-BB-7866 71 116 Treatment Chemotherapy Cisplatin complete response No No TCGA-BB-7866 70 116 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 7000.00 No External gy TCGA-BB-7870 64 119 Treatment Radiation Therapy Radiation 1 complete response 6000 No cgy TCGA-BB-7871 143 185 Treatment Radiation Therapy Radiation 1 complete response No TCGA-BB-7872 112 154 Treatment Chemotherapy Cisplatin complete response No No TCGA-BB-7872 112 154 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6600.00 No External cgy TCGA-BB-A5HU 69 97 Treatment Chemotherapy Cisplatin complete response No No TCGA-BB-A5HU 68 110 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6600.00 No External cgy TCGA-BB-A5HY 84 121 Treatment Chemotherapy Cisplatin complete response No No TCGA-BB-A5HY 83 127 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 182 No External gy TCGA-BB-A5HY 275 281 Treatment Radiation Therapy Radiation 2 radiographic progressive disease Distant Recurrence 5 2500 No External cgy TCGA-BB-A5HZ 94 136 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6300 No External cgy TCGA-BB-A6UM 150 181 Treatment Chemotherapy complete response No No TCGA-BB-A6UM 150 181 Treatment Radiation Therapy Radiation 1 complete response No TCGA-BB-A6UO 105 150 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6600 No External cgy TCGA-CN-4726 90 94 Treatment Chemotherapy Cisplatin 1 100 mg/m2/wk 1 Recurrence IV No TCGA-CN-4726 90 94 Treatment Radiation Therapy Radiation 1 Recurrence Regional Site 2 5 1100 No External Beam cgy TCGA-CN-4727 83 143 Treatment Chemotherapy Cisplatin mg/m2/wk 1 Adjuvant IV No mg/m2/wk TCGA-CN-4727 94 143 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 No External Beam cgy TCGA-CN-4728 44 87 Treatment Chemotherapy Panitumumab 7 2.5 mg/kg 1 Adjuvant IV No mg/kg TCGA-CN-4728 44 87 Treatment Chemotherapy Cisplatin 7 30 mg/m2/wk 1 Adjuvant IV No TCGA-CN-4728 44 87 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CN-4731 273 301 Treatment Chemotherapy Cetuximab mg/m2/wk 1 Recurrence IV No mg/m2/wk TCGA-CN-4731 546 560 Treatment Chemotherapy Cetuximab 3 100 mg/ml 1 Recurrence IV No 300 mg/ml TCGA-CN-4731 827 869 Treatment Chemotherapy Cetuximab clinical progressive disease No No TCGA-CN-4731 937 958 Treatment Chemotherapy Docetaxel clinical progressive disease No Yes TCGA-CN-4731 273 323 Treatment Radiation Therapy Radiation 1 Recurrence Local Recurrence 2 35 7000 No External Beam cgy TCGA-CN-4731 538 562 Treatment Radiation Therapy Radiation 2 Recurrence Regional Site 3 5 4400 No Other cgy TCGA-CN-4734 73 115 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 5400 No External Beam cgy TCGA-CN-4735 46 88 Treatment Chemotherapy Panitumumab 2.5 mg/kg 1 Adjuvant IV No TCGA-CN-4735 46 88 Treatment Chemotherapy Cisplatin 3 30 mg/m2/wk 1 Adjuvant IV No TCGA-CN-4735 46 88 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CN-4736 262 322 Treatment Chemotherapy Cisplatin mg/m2 1 Recurrence IV No mg/m2 TCGA-CN-4736 269 322 Treatment Radiation Therapy Radiation 1 Recurrence Regional Site 2 35 7000 No External Beam cgy TCGA-CN-4737 43 85 Treatment Chemotherapy Cisplatin mg/ml 1 Adjuvant IV No 50 mg/ml TCGA-CN-4737 43 85 Treatment Chemotherapy Panitumumab mg/ml 1 Adjuvant IV No 100 mg/ml TCGA-CN-4737 43 85 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CN-4738 251 280 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 3200 No External Beam cgy TCGA-CN-4739 115 161 Treatment Chemotherapy Carboplatin auc Adjuvant IV No auc TCGA-CN-4739 115 161 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 31 6200 No External Beam cgy TCGA-CN-4740 260 276 Treatment Chemotherapy Cetuximab mg/ml 1 Recurrence IV No mg/ml TCGA-CN-4740 757 791 Treatment Chemotherapy Everolimus 1 mg/ml 1 Recurrence IV No mg/ml TCGA-CN-4740 266 276 Treatment Radiation Therapy Radiation 1 Recurrence Regional Site 2 5 4400 No Other cgy TCGA-CN-4740 98 160 Treatment Radiation Therapy Radiation 2 Adjuvant Primary Tumor Field 1 36 6480 No External Beam cgy TCGA-CN-4741 103 163 Treatment Chemotherapy Cisplatin mg 1 Adjuvant IV No mg TCGA-CN-4741 1771 1778 Treatment Immunotherapy Cetuximab complete response No No TCGA-CN-4741 103 163 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 6600 No External Beam cgy TCGA-CN-4741 1771 1780 Treatment Radiation Therapy Radiation 2 complete response Regional Site 5 4400 No External cgy TCGA-CN-4742 168 237 Treatment Chemotherapy Cisplatin auc Adjuvant IV No auc TCGA-CN-4742 165 237 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 41 7380 No External Beam cgy TCGA-CN-5358 223 Treatment Chemotherapy Carboplatin auc 2 Recurrence IV Yes auc TCGA-CN-5358 202 Treatment Chemotherapy Cisplatin auc 1 Recurrence IV Yes auc TCGA-CN-5358 202 Treatment Radiation Therapy Radiation 1 Recurrence Regional Site 2 Yes External Beam cgy TCGA-CN-5359 54 79 Treatment Chemotherapy Cisplatin 10 mg/ml 1 Adjuvant IV No 80 mg/ml TCGA-CN-5359 54 79 Treatment Chemotherapy Panitumumab 20 mg/ml 1 Adjuvant IV No 160 mg/ml TCGA-CN-5359 53 96 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CN-5360 80 125 Treatment Chemotherapy Cisplatin 3 mg 1 Adjuvant IV No mg TCGA-CN-5360 80 122 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CN-5364 231 303 Treatment Chemotherapy Carboplatin mg 1 Adjuvant IV No mg TCGA-CN-5364 231 303 Treatment Chemotherapy Paclitaxel mg 1 Adjuvant IV No mg TCGA-CN-5364 231 289 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 35 6640 No External Beam cgy TCGA-CN-5366 86 147 Treatment Chemotherapy mg 1 Adjuvant IV No mg TCGA-CN-5366 94 151 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 5500 No External Beam cgy TCGA-CN-5367 88 139 Treatment Chemotherapy Cisplatin mg 1 Adjuvant IV No mg TCGA-CN-5367 83 139 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 6000 No External Beam cgy TCGA-CN-5370 142 183 Treatment Chemotherapy Cisplatin 3 mg/ml 1 Recurrence IV No mg/ml TCGA-CN-5370 142 183 Treatment Chemotherapy Cisplatin 3 mg/ml 3 Recurrence IV No mg/ml TCGA-CN-5370 142 183 Treatment Chemotherapy Cisplatin 3 mg/ml 2 Recurrence IV No mg/ml TCGA-CN-5370 144 199 Treatment Radiation Therapy Radiation 1 Recurrence Primary Tumor Field 2 34 6800 No External Beam cgy TCGA-CN-5373 66 109 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CN-5374 112 182 Treatment Chemotherapy Cisplatin mg 1 Adjuvant INTRAVESICAL No mg TCGA-CN-5374 116 187 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 34 7200 No External Beam cgy TCGA-CN-6010 50 70 Treatment Chemotherapy Cisplatin 2 10 mg/ml 1 Adjuvant IV No 10 mg/ml TCGA-CN-6010 47 98 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CN-6011 109 159 Treatment Chemotherapy Cisplatin mg/ml 1 Adjuvant IV No mg/ml TCGA-CN-6011 102 157 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-CN-6012 157 200 Treatment Chemotherapy Cisplatin mg/ml 1 Adjuvant IV No mg/ml TCGA-CN-6012 157 207 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 No External Beam cgy TCGA-CN-6013 103 148 Treatment Chemotherapy Cisplatin 3 100 mg/m2 1 Adjuvant IV No 100 mg/m2 TCGA-CN-6013 103 148 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-CN-6016 92 141 Treatment Chemotherapy Carboplatin 2 auc 1 Adjuvant IV No 2 auc TCGA-CN-6016 93 156 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 39 7020 No External Beam cgy TCGA-CN-6017 103 110 Treatment Chemotherapy Carboplatin 50 mg/ml 1 Adjuvant IV No 50 mg/ml TCGA-CN-6017 75 96 Treatment Chemotherapy Cisplatin 10 mg/ml 1 Adjuvant IV No 10 mg/ml TCGA-CN-6017 75 117 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-CN-6019 56 84 Treatment Chemotherapy Cisplatin 10 mg/ml 1 Adjuvant IV No 10 mg/ml TCGA-CN-6019 56 91 Treatment Chemotherapy Panitumumab 20 mg/ml 1 Adjuvant IV No 20 mg/ml TCGA-CN-6019 56 97 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CN-6020 101 140 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CN-6022 166 185 Treatment Radiation Therapy Radiation 1 Progression Regional Site 2 10 1800 No External Beam cgy TCGA-CN-6023 49 99 Treatment Chemotherapy Cetuximab mg/ml 1 Adjuvant IV No mg/ml TCGA-CN-6023 49 99 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 35 6300 No External Beam cgy TCGA-CN-6989 73 114 Treatment Chemotherapy Carboplatin 4 50 mg/ml 1 Adjuvant IV No 200 mg/ml TCGA-CN-6989 791 855 Treatment Chemotherapy Gemcitabine clinical progressive disease No No TCGA-CN-6989 889 917 Treatment Chemotherapy Methotrexate clinical progressive disease No No TCGA-CN-6989 72 116 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 32 6400 No External Beam cgy TCGA-CN-6992 71 Treatment Chemotherapy Cisplatin 3 10 mg/ml 1 Adjuvant IV Yes 30 mg/ml TCGA-CN-6992 70 140 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-CN-6996 70 Treatment Chemotherapy Cisplatin 3 10 mg/ml 1 Adjuvant IV Yes 30 mg/ml TCGA-CN-6996 378 378 Treatment Targeted Molecular Therapy Capecitabine clinical progressive disease No Yes TCGA-CN-6996 378 378 Treatment Targeted Molecular Therapy Vorinostat clinical progressive disease No Yes TCGA-CN-6996 418 Treatment Vaccine Vaccine Nos clinical progressive disease Yes Yes TCGA-CN-6996 71 119 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-CN-6997 59 101 Treatment Chemotherapy Cisplatin 3 mg/ml 1 Adjuvant IV No mg/ml TCGA-CN-6997 363 Treatment Chemotherapy Cetuximab Yes No TCGA-CN-6997 70 113 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 6600 No External Beam cgy TCGA-CN-6998 64 131 Treatment Chemotherapy Cisplatin clinical progressive disease No No TCGA-CN-6998 63 141 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 38 6840 No External cgy TCGA-CN-A498 59 101 Treatment Chemotherapy Carboplatin complete response No No TCGA-CN-A498 480 487 Treatment Chemotherapy Cetuximab clinical progressive disease No No TCGA-CN-A498 674 723 Treatment Chemotherapy Cetuximab clinical progressive disease No No TCGA-CN-A498 744 751 Treatment Chemotherapy Carboplatin clinical progressive disease No No TCGA-CN-A498 744 751 Treatment Chemotherapy Paclitaxel clinical progressive disease No No TCGA-CN-A498 51 107 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 6440 No External cgy TCGA-CN-A498 480 493 Treatment Radiation Therapy Radiation 2 radiographic progressive disease Regional Site 5 44 No External gy TCGA-CN-A49A 76 126 Treatment Chemotherapy Carboplatin complete response No No TCGA-CN-A49A 76 128 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 6600 No External cgy TCGA-CN-A49A 365 365 Treatment Radiation Therapy Radiation 2 radiographic progressive disease Distant Recurrence 1 1500 No External cgy TCGA-CN-A49B 161 213 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 6600 No External cgy TCGA-CN-A49C 26 78 Treatment Chemotherapy Cetuximab complete response No No TCGA-CN-A49C 26 78 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 34 7300 No External cgy TCGA-CN-A63T 64 64 Treatment Chemotherapy Cisplatin complete response No No TCGA-CN-A63T 64 72 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 5 9 No External gy TCGA-CN-A63U 36 86 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 60 No External gy TCGA-CN-A63W 69 138 Treatment Chemotherapy Panitumumab complete response No Yes TCGA-CN-A63W 69 138 Treatment Chemotherapy Cisplatin complete response No Yes TCGA-CN-A63W 69 138 Treatment Chemotherapy Carboplatin complete response No Yes TCGA-CN-A63W 69 145 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 66 No External gy TCGA-CN-A641 187 239 Treatment Chemotherapy Cisplatin complete response No No TCGA-CN-A641 185 239 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CN-A6UY 59 106 Treatment Chemotherapy Carboplatin complete response No No TCGA-CN-A6UY 59 101 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6900 No External cgy TCGA-CN-A6V1 13 34 Treatment Immunotherapy Cetuximab complete response No Yes TCGA-CN-A6V3 130 151 Treatment Chemotherapy Cisplatin complete response No No TCGA-CN-A6V3 130 178 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-CN-A6V6 74 116 Treatment Chemotherapy Cisplatin complete response No No TCGA-CN-A6V6 74 119 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-CN-A6V7 83 104 Treatment Chemotherapy Cisplatin complete response No No TCGA-CN-A6V7 83 132 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 7000 No External cgy TCGA-CQ-5323 47 83 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 25 5000 No External Beam cgy TCGA-CQ-5325 244 276 Treatment Radiation Therapy Radiation 1 Recurrence Primary Tumor Field 1 25 6000 No External Beam cgy TCGA-CQ-5326 64 73 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 8 1696 No External Beam cgy TCGA-CQ-5327 57 57 Treatment Chemotherapy Cisplatin 1 150 mg 1 Adjuvant IV No 150 mg TCGA-CQ-5327 54 99 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-CQ-5330 57 88 Treatment Chemotherapy 1 Adjuvant IV No TCGA-CQ-5330 57 88 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-CQ-5333 223 244 Treatment Radiation Therapy Radiation 1 Palliative Primary Tumor Field 1 3 2400 No External Beam cgy TCGA-CQ-5334 55 69 Treatment Radiation Therapy Radiation 1 Palliative Primary Tumor Field 1 10 2508 No External Beam cgy TCGA-CQ-6218 90 121 Treatment Chemotherapy Cisplatin 2 260 mg 1 Adjuvant IV No 260 mg TCGA-CQ-6218 90 129 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CQ-6219 286 324 Treatment Radiation Therapy Radiation 1 Recurrence Local Recurrence 1 35 7000 No External Beam cgy TCGA-CQ-6224 61 81 Treatment Chemotherapy Cisplatin 2 170 mg 1 Adjuvant IV No 340 mg TCGA-CQ-6224 61 103 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CQ-6225 49 91 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 18 4320 No External Beam cgy TCGA-CQ-6228 315 319 Treatment Radiation Therapy Radiation 1 Recurrence Distant Recurrence 2 5 2000 No External Beam cgy TCGA-CQ-6228 154 186 Treatment Radiation Therapy Radiation 2 Adjuvant Primary Tumor Field 1 25 6000 No External Beam cgy TCGA-CQ-7064 116 162 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-CQ-7065 249 291 Treatment Chemotherapy Cisplatin 3 197 mg 1 Recurrence IV No 477 mg TCGA-CQ-7065 248 294 Treatment Radiation Therapy Radiation 1 Recurrence Primary Tumor Field 1 35 7000 No External Beam cgy TCGA-CQ-7068 1248 1302 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 35 7000 No External cgy TCGA-CQ-7071 107 155 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-CQ-7072 116 158 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-CQ-A4CD 156 204 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-CQ-A4CH 120 148 Treatment Chemotherapy Cisplatin partial response No No TCGA-CQ-A4CH 119 163 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-CQ-A4CI 118 163 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-CR-5243 16 72 Treatment Chemotherapy Carboplatin 9 340 mg 1 Other, Specify In Notes IV No TCGA-CR-5243 90 139 Treatment Chemotherapy Carboplatin 7 178 mg 2 Other, Specify In Notes IV No TCGA-CR-5243 91 139 Treatment Chemotherapy Paclitaxel 7 69 mg 2 Other, Specify In Notes IV No TCGA-CR-5243 16 72 Treatment Chemotherapy Paclitaxel 9 138 mg 1 Other, Specify In Notes IV No TCGA-CR-5243 90 139 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Regional Site 1 33 5610 No External Beam cgy TCGA-CR-5243 90 139 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Primary Tumor Field 1 33 6930 No External Beam cgy TCGA-CR-5247 19 80 Treatment Chemotherapy Paclitaxel complete response No No TCGA-CR-5247 19 80 Treatment Chemotherapy Carboplatin complete response No No TCGA-CR-5247 21 71 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Regional Site 1 33 5610 No External Beam cgy TCGA-CR-5247 21 71 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 33 6930 No External Beam cgy TCGA-CR-5247 21 71 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Primary Tumor Field 1 33 6930 No External Beam cgy TCGA-CR-5248 42 84 Treatment Chemotherapy Oxaliplatin No Yes TCGA-CR-5248 42 84 Treatment Chemotherapy Pemetrexed No Yes TCGA-CR-5248 137 179 Treatment Chemotherapy Paclitaxel complete response No No TCGA-CR-5248 137 179 Treatment Chemotherapy Carboplatin complete response No No TCGA-CR-5248 1124 1152 Treatment Chemotherapy Bevacizumab clinical progressive disease No Yes TCGA-CR-5248 1124 1152 Treatment Chemotherapy Docetaxel clinical progressive disease No Yes TCGA-CR-5248 1124 1152 Treatment Chemotherapy Cisplatin clinical progressive disease No Yes TCGA-CR-5248 1194 1208 Treatment Immunotherapy Cixutumumab No Yes TCGA-CR-5248 137 183 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 33 6930 No External Beam cgy TCGA-CR-5248 137 183 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 33 6930 No External Beam cgy TCGA-CR-5249 102 140 Treatment Chemotherapy Cetuximab mg 1 Adjuvant IV No TCGA-CR-5249 107 140 Treatment Radiation Therapy Radiation 1 Adjuvant Regional Site 1 30 6000 No External Beam cgy TCGA-CR-5249 107 140 Treatment Radiation Therapy Radiation 2 Adjuvant Regional Site 1 30 5700 No External Beam cgy TCGA-CR-5249 107 140 Treatment Radiation Therapy Radiation 3 Adjuvant Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-CR-5250 57 136 Treatment Chemotherapy Cisplatin 232 mg 1 Other, Specify In Notes IV No TCGA-CR-5250 56 113 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Regional Site 1 30 5400 No External Beam cgy TCGA-CR-5250 56 113 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Primary Tumor Field 1 38 6840 No External Beam cgy TCGA-CR-6467 75 118 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 5400 No External Beam cgy TCGA-CR-6467 75 118 Treatment Radiation Therapy Radiation 2 Adjuvant Regional Site 1 30 6000 No External Beam cgy TCGA-CR-6470 85 113 Treatment Chemotherapy Paclitaxel 5 221 mg 1 Adjuvant IV No 1105 mg TCGA-CR-6470 85 113 Treatment Chemotherapy Carboplatin 5 70 mg 1 Adjuvant IV No 350 mg TCGA-CR-6470 79 115 Treatment Radiation Therapy Radiation 1 Adjuvant Regional Site 1 27 5130 No External Beam cgy TCGA-CR-6470 79 115 Treatment Radiation Therapy Radiation 2 Adjuvant Regional Site 1 27 5400 No External Beam cgy TCGA-CR-6470 79 115 Treatment Radiation Therapy Radiation 3 Adjuvant Primary Tumor Field 1 27 5400 No External Beam cgy TCGA-CR-6471 1052 1052 Treatment Chemotherapy Cetuximab 1 400 mg/m2 3 Palliative IV No TCGA-CR-6471 548 595 Treatment Chemotherapy Paclitaxel 8 60 mg/m2 1 Recurrence IV No TCGA-CR-6471 618 646 Treatment Chemotherapy Carboplatin 5 1.5 auc 2 Recurrence IV No TCGA-CR-6471 1108 1129 Treatment Chemotherapy Docetaxel 4 40 mg/m2 5 Palliative IV No TCGA-CR-6471 548 595 Treatment Chemotherapy Carboplatin 8 2 auc 1 Recurrence IV No TCGA-CR-6471 618 646 Treatment Chemotherapy Paclitaxel 5 35 mg/m2 2 Recurrence IV No TCGA-CR-6471 1059 1087 Treatment Chemotherapy Methotrexate 5 30 mg/m2 4 Palliative IV No TCGA-CR-6471 77 114 Treatment Radiation Therapy Radiation 1 Adjuvant Regional Site 1 27 5130 No External Beam cgy TCGA-CR-6471 614 646 Treatment Radiation Therapy Radiation 2 Recurrence Regional Site 2 50 6250 No External Beam cgy TCGA-CR-6471 77 114 Treatment Radiation Therapy Radiation 3 Adjuvant Primary Tumor Field 1 27 5400 No External Beam cgy TCGA-CR-6471 614 646 Treatment Radiation Therapy Radiation 4 Recurrence Primary Tumor Field 2 50 6250 No External Beam cgy TCGA-CR-6471 1081 1081 Treatment Radiation Therapy Radiation 5 Palliative Distant Recurrence 4 No Other cgy TCGA-CR-6471 77 114 Treatment Radiation Therapy Radiation 6 Adjuvant Regional Site 1 27 5400 No External Beam cgy TCGA-CR-6471 839 Treatment Radiation Therapy Radiation 7 Recurrence Regional Site 3 No External Beam cgy TCGA-CR-6472 109 123 Treatment Chemotherapy Carboplatin 3 1 auc 2 Other, Specify In Notes IV No TCGA-CR-6472 109 123 Treatment Chemotherapy Paclitaxel 3 30 mg/m2 2 Other, Specify In Notes IV No TCGA-CR-6472 28 84 Treatment Chemotherapy Paclitaxel 9 60 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6472 28 84 Treatment Chemotherapy Carboplatin 9 2 auc 1 Other, Specify In Notes IV No TCGA-CR-6472 109 154 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 33 6930 No External Beam cgy TCGA-CR-6472 109 154 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 33 5610 No External Beam cgy TCGA-CR-6472 109 154 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Regional Site 1 33 6930 No External Beam cgy TCGA-CR-6473 47 94 Treatment Chemotherapy Paclitaxel 3 30 mg/m2 2 Other, Specify In Notes IV No TCGA-CR-6473 19 40 Treatment Chemotherapy Paclitaxel 4 60 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6473 19 40 Treatment Chemotherapy Carboplatin 4 2 auc 1 Other, Specify In Notes IV No TCGA-CR-6473 47 94 Treatment Chemotherapy Carboplatin 2 1 auc 2 Other, Specify In Notes IV No TCGA-CR-6473 45 94 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Regional Site 1 33 5610 No External Beam cgy TCGA-CR-6473 45 94 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Primary Tumor Field 1 33 6930 No External Beam cgy TCGA-CR-6473 45 94 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Regional Site 1 33 6930 No External Beam cgy TCGA-CR-6474 108 150 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CR-6477 77 84 Treatment Chemotherapy Paclitaxel 2 30 mg/m2 2 Other, Specify In Notes IV No TCGA-CR-6477 10 66 Treatment Chemotherapy Carboplatin 8 2 auc 1 Other, Specify In Notes IV No TCGA-CR-6477 10 66 Treatment Chemotherapy Paclitaxel 8 60 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6477 77 84 Treatment Chemotherapy Carboplatin 2 1 auc 2 Other, Specify In Notes IV No TCGA-CR-6477 78 123 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 32 6720 No External Beam cgy TCGA-CR-6477 78 123 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 24 5040 No External Beam cgy TCGA-CR-6477 78 123 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Primary Tumor Field 1 24 5040 No External Beam cgy TCGA-CR-6478 125 162 Treatment Chemotherapy Paclitaxel 5 30 mg/m2 2 Other, Specify In Notes IV No TCGA-CR-6478 125 162 Treatment Chemotherapy Carboplatin 5 1 auc 2 Other, Specify In Notes IV No TCGA-CR-6478 44 107 Treatment Chemotherapy Paclitaxel 9 60 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6478 44 107 Treatment Chemotherapy Carboplatin 9 2 auc 1 Other, Specify In Notes IV No TCGA-CR-6478 125 178 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Regional Site 1 27 5400 No External Beam cgy TCGA-CR-6478 125 178 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 3 1890 No External Beam cgy TCGA-CR-6478 125 178 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Primary Tumor Field 1 24 5040 No External Beam cgy TCGA-CR-6480 27 85 Treatment Chemotherapy Cisplatin 3 75 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6480 27 85 Treatment Chemotherapy Cetuximab 3 900 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6480 27 85 Treatment Chemotherapy Paclitaxel 3 270 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6480 103 145 Treatment Chemotherapy Cetuximab 7 250 mg/m2 2 Other, Specify In Notes IV No TCGA-CR-6480 103 152 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 27 5400 No External Beam cgy TCGA-CR-6480 103 152 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 27 5130 No External Beam cgy TCGA-CR-6480 103 152 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Regional Site 1 35 7000 No External Beam cgy TCGA-CR-6481 31 73 Treatment Chemotherapy Paclitaxel 5 30 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6481 31 73 Treatment Chemotherapy Carboplatin 5 1 auc 1 Other, Specify In Notes IV No TCGA-CR-6481 29 74 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 33 6930 No External Beam cgy TCGA-CR-6481 29 74 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 24 5040 No External Beam cgy TCGA-CR-6481 29 74 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Regional Site 1 33 6930 No External Beam cgy TCGA-CR-6482 74 74 Treatment Chemotherapy Paclitaxel 1 90 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6482 158 193 Treatment Chemotherapy Paclitaxel 6 30 mg/m2 3 Other, Specify In Notes IV No TCGA-CR-6482 74 74 Treatment Chemotherapy Cetuximab 1 400 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6482 158 193 Treatment Chemotherapy Carboplatin 6 1 auc 3 Other, Specify In Notes IV No TCGA-CR-6482 88 137 Treatment Chemotherapy Paclitaxel 8 60 mg/m2 2 Other, Specify In Notes IV No TCGA-CR-6482 74 74 Treatment Chemotherapy Cisplatin 1 75 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6482 88 137 Treatment Chemotherapy Carboplatin 8 2 auc 2 Other, Specify In Notes IV No TCGA-CR-6482 154 198 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 33 6930 No External Beam cgy TCGA-CR-6482 154 198 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 24 5040 No External Beam cgy TCGA-CR-6482 154 198 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Regional Site 1 33 6930 No External Beam cgy TCGA-CR-6484 109 144 Treatment Chemotherapy Paclitaxel 6 30 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-6484 109 144 Treatment Chemotherapy Carboplatin 6 1 auc 1 Other, Specify In Notes IV No TCGA-CR-6484 109 154 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-CR-6484 109 154 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 25 5000 No External Beam cgy TCGA-CR-6484 109 154 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Regional Site 1 33 6600 No External Beam cgy TCGA-CR-6491 191 201 Treatment Chemotherapy Carboplatin complete response No No TCGA-CR-6491 191 201 Treatment Chemotherapy Docetaxel complete response No No TCGA-CR-6491 191 201 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field No External TCGA-CR-6492 114 145 Treatment Radiation Therapy Radiation 1 Adjuvant 1 No External Beam TCGA-CR-6493 100 150 Treatment Chemotherapy Paclitaxel complete response No No TCGA-CR-6493 100 150 Treatment Chemotherapy Carboplatin complete response No No TCGA-CR-6493 100 150 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 7000 No External cgy TCGA-CR-7365 140 192 Treatment Chemotherapy 1 Adjuvant No TCGA-CR-7365 140 192 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 No External Beam TCGA-CR-7367 90 98 Treatment Chemotherapy Paclitaxel No No TCGA-CR-7367 90 98 Treatment Chemotherapy Carboplatin No No TCGA-CR-7367 95 132 Treatment Radiation Therapy Radiation 1 Adjuvant Regional Site 1 27 5130 No External Beam cgy TCGA-CR-7367 95 132 Treatment Radiation Therapy Radiation 2 Adjuvant Regional Site 1 27 5400 No External Beam cgy TCGA-CR-7367 95 132 Treatment Radiation Therapy Radiation 3 Adjuvant Primary Tumor Field 1 27 5400 No External Beam cgy TCGA-CR-7370 28 80 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 28 5400 No External Beam cgy TCGA-CR-7373 96 138 Treatment Chemotherapy Cisplatin 1 Adjuvant IV No TCGA-CR-7373 96 138 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 No External Beam TCGA-CR-7379 126 162 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 25 5000 No External Beam cgy TCGA-CR-7379 126 169 Treatment Radiation Therapy Radiation 2 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-CR-7380 92 153 Treatment Chemotherapy 1 Adjuvant IV No TCGA-CR-7380 100 150 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 33 6600 No External Beam cgy TCGA-CR-7380 100 140 Treatment Radiation Therapy Radiation 2 Adjuvant Primary Tumor Field 1 25 5000 No External Beam cgy TCGA-CR-7383 462 483 Treatment Chemotherapy Paclitaxel partial response No No TCGA-CR-7383 462 483 Treatment Chemotherapy Carboplatin partial response No No TCGA-CR-7385 29 87 Treatment Chemotherapy 1 Adjuvant IV No TCGA-CR-7385 29 87 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 No External Beam TCGA-CR-7386 97 132 Treatment Chemotherapy Paclitaxel 6 30 mg/m2 1 Adjuvant IV No TCGA-CR-7386 97 132 Treatment Chemotherapy Carboplatin 6 1 auc 1 Adjuvant IV No TCGA-CR-7386 96 135 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 29 5800 No External Beam cgy TCGA-CR-7386 96 135 Treatment Radiation Therapy Radiation 2 Adjuvant Regional Site 1 29 4390 No External Beam cgy TCGA-CR-7388 65 93 Treatment Chemotherapy Carboplatin 5 2 auc 1 Other, Specify In Notes IV No TCGA-CR-7388 114 121 Treatment Chemotherapy Paclitaxel 2 30 mg/m2 2 Other, Specify In Notes IV No TCGA-CR-7388 705 733 Treatment Chemotherapy Cetuximab 3 Palliative IV No TCGA-CR-7388 114 121 Treatment Chemotherapy Carboplatin 2 1 auc 2 Other, Specify In Notes IV No TCGA-CR-7388 65 93 Treatment Chemotherapy Paclitaxel 5 60 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-7388 110 148 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Regional Site 1 21 3570 No External Beam cgy TCGA-CR-7388 110 148 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Primary Tumor Field 1 21 4410 No External Beam cgy TCGA-CR-7388 110 148 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Regional Site 1 21 4410 No External Beam cgy TCGA-CR-7389 31 73 Treatment Chemotherapy Paclitaxel complete response No No TCGA-CR-7389 31 73 Treatment Chemotherapy Carboplatin complete response No No TCGA-CR-7389 31 75 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Regional Site 1 33 6930 No External Beam cgy TCGA-CR-7389 31 75 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 33 5610 No External Beam cgy TCGA-CR-7389 31 75 Treatment Radiation Therapy Radiation 3 Other, Specify In Notes Primary Primary Tumor Field 1 33 6930 No External Beam cgy TCGA-CR-7390 134 176 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 21 6000 No External cgy TCGA-CR-7390 134 176 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5000 No External TCGA-CR-7392 109 151 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 6000 No External TCGA-CR-7392 109 151 Treatment Radiation Therapy Radiation 2 complete response Regional Site 5400 No External TCGA-CR-7393 -303 105 Treatment Chemotherapy Paclitaxel complete response No No TCGA-CR-7393 63 105 Treatment Chemotherapy Carboplatin complete response No No TCGA-CR-7393 62 104 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field No External TCGA-CR-7394 106 126 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 15 3000 No External cgy TCGA-CR-7394 106 126 Treatment Radiation Therapy Radiation 2 complete response Regional Site 15 3000 No External cgy TCGA-CR-7397 63 99 Treatment Chemotherapy Paclitaxel complete response No No TCGA-CR-7397 63 99 Treatment Chemotherapy Carboplatin complete response No No TCGA-CR-7397 61 100 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 27 4860 No External cgy TCGA-CR-7397 61 100 Treatment Radiation Therapy Radiation 2 complete response Regional Site 27 6000 No External cgy TCGA-CR-7397 61 100 Treatment Radiation Therapy Radiation 3 complete response Regional Site 27 4860 No External cgy TCGA-CR-7402 37 101 Treatment Chemotherapy Carboplatin 1.5 auc 1 Other, Specify In Notes IV No TCGA-CR-7402 37 101 Treatment Chemotherapy Paclitaxel 40 mg/m2 1 Other, Specify In Notes IV No TCGA-CR-7402 36 101 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 7020 No External Beam cgy TCGA-CR-7402 36 101 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 5040 No External Beam cgy TCGA-CR-7404 18 67 Treatment Chemotherapy Paclitaxel No No TCGA-CR-7404 1297 1318 Treatment Chemotherapy clinical progressive disease phase i trial No Yes TCGA-CR-7404 1332 1416 Treatment Chemotherapy Pemetrexed No No TCGA-CR-7404 18 67 Treatment Chemotherapy Carboplatin No No TCGA-CR-7404 85 135 Treatment Chemotherapy Paclitaxel complete response No No TCGA-CR-7404 85 135 Treatment Chemotherapy Carboplatin complete response No No TCGA-CR-7404 298 354 Treatment Chemotherapy Cetuximab partial response No No TCGA-CR-7404 375 415 Treatment Chemotherapy Capecitabine No No TCGA-CR-7404 466 599 Treatment Chemotherapy Cetuximab No No TCGA-CR-7404 606 634 Treatment Chemotherapy Paclitaxel stable disease No No TCGA-CR-7404 1052 1080 Treatment Chemotherapy Methotrexate No No TCGA-CR-7404 78 137 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Primary Primary Tumor Field 1 33 6930 No External Beam cgy TCGA-CR-7404 78 137 Treatment Radiation Therapy Radiation 2 Other, Specify In Notes Primary Regional Site 1 33 5610 No External Beam cgy TCGA-CR-7404 78 137 Treatment Radiation Therapy Radiation 4 Other, Specify In Notes Primary Regional Site 1 33 6930 No External Beam cgy TCGA-CV-5430 1641 1702 Treatment Chemotherapy Carboplatin 4 Recurrence IV No TCGA-CV-5430 1641 1702 Treatment Chemotherapy Paclitaxel 4 Recurrence IV No TCGA-CV-5430 1641 1702 Treatment Chemotherapy Irinotecan 4 Recurrence IV No TCGA-CV-5430 379 382 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 4 50 No External Beam cgy TCGA-CV-5431 28 69 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 9 7000 No External Beam cgy TCGA-CV-5434 3246 3259 Treatment Chemotherapy Carboplatin 2 Recurrence IV No TCGA-CV-5434 3246 3259 Treatment Chemotherapy Paclitaxel 2 Recurrence IV No TCGA-CV-5434 45 87 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 6000 No External Beam cgy TCGA-CV-5435 28 63 Treatment Chemotherapy Carboplatin 2 Adjuvant IV No TCGA-CV-5435 305 336 Treatment Chemotherapy Paclitaxel Recurrence IV No TCGA-CV-5435 305 336 Treatment Chemotherapy Carboplatin Recurrence IV No TCGA-CV-5435 21 62 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 30 6000 No External Beam cgy TCGA-CV-5439 231 345 Treatment Chemotherapy Carboplatin 6 Recurrence IV No TCGA-CV-5439 378 440 Treatment Chemotherapy Gefitinib 2 Palliative PO No TCGA-CV-5439 64 108 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 33 4500 No External Beam cgy TCGA-CV-5440 19 Treatment Chemotherapy Paclitaxel Adjuvant IV Yes TCGA-CV-5440 28 86 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 30 60 No External Beam cgy TCGA-CV-5441 52 89 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 30 60 No External Beam TCGA-CV-5966 33 78 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 20 40 No External gy TCGA-CV-5966 33 78 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 50 No External gy TCGA-CV-5973 50 80 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-5977 40 82 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-5977 40 82 Treatment Radiation Therapy Radiation 2 complete response Regional Site 21 42 No External gy TCGA-CV-5979 43 84 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 30 6000 No External Beam cgy TCGA-CV-6936 73 134 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 30 66 No External gy TCGA-CV-6941 31 70 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 62 No External gy TCGA-CV-6941 31 70 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 50 No External gy TCGA-CV-6950 26 56 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 63 No External TCGA-CV-6954 48 89 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External TCGA-CV-6954 48 89 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 50 No External TCGA-CV-6959 140 160 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 15 45 No External gy TCGA-CV-7090 69 108 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 2 60 No External gy TCGA-CV-7090 69 108 Treatment Radiation Therapy Radiation 2 complete response Regional Site 2 50 No External gy TCGA-CV-7235 46 81 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 20 40 No External gy TCGA-CV-7235 43 81 Treatment Radiation Therapy Radiation 2 complete response Regional Site 10 20 No External gy TCGA-CV-7238 86 127 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-7250 28 84 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External TCGA-CV-7252 33 89 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 35 63 No External gy TCGA-CV-7416 334 334 Treatment Chemotherapy Cisplatin No No TCGA-CV-7416 0 Treatment Radiation Therapy Radiation 1 Other, Specify In Notes Neoadjuvant Primary Tumor Field External Beam TCGA-CV-7418 62 Treatment Radiation Therapy Radiation 1 complete response No TCGA-CV-7418 509 567 Treatment Radiation Therapy Radiation 2 Local Recurrence 31 60 No External gy TCGA-CV-7422 41 78 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 30 No External gy TCGA-CV-7422 41 78 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 50 No External gy TCGA-CV-7429 70 Treatment Radiation Therapy Radiation 1 partial response Primary Tumor Field 12 36 No External gy TCGA-CV-7435 43 87 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 30 No External gy TCGA-CV-7435 -291 87 Treatment Radiation Therapy Radiation 2 complete response Regional Site 27 54 No External gy TCGA-CV-7435 -291 87 Treatment Radiation Therapy Radiation 3 complete response Regional Site 14 42 No External gy TCGA-CV-A45R 39 78 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 31 62 No External gy TCGA-CV-A45R 39 78 Treatment Radiation Therapy Radiation 2 complete response Regional Site 13 39 No External gy TCGA-CV-A45U 31 70 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-A45U 31 70 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 50 No External gy TCGA-CV-A45X 68 107 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-A45X 68 107 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 50 No External gy TCGA-CV-A45Y 37 78 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-A45Z 965 1004 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-A460 28 69 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 21 42 No External gy TCGA-CV-A461 39 52 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-A461 39 52 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 54 No External gy TCGA-CV-A464 70 108 Treatment Radiation Therapy Radiation 1 complete response Local Recurrence 30 60 No External gy TCGA-CV-A464 70 108 Treatment Radiation Therapy Radiation 2 complete response Local Recurrence 30 57 No External gy TCGA-CV-A464 70 108 Treatment Radiation Therapy Radiation 3 complete response Regional Site 30 54 No External gy TCGA-CV-A468 26 67 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 21 42 No External gy TCGA-CV-A468 26 67 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 50 No External gy TCGA-CV-A468 26 67 Treatment Radiation Therapy Radiation 3 complete response Regional Site 14 42 No External gy TCGA-CV-A6JD 41 80 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-A6JD 41 80 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 50 No External gy TCGA-CV-A6JN 39 77 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-A6JN 39 77 Treatment Radiation Therapy Radiation 2 complete response Regional Site 30 57 No External gy TCGA-CV-A6JO 28 69 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 30 60 No External gy TCGA-CV-A6JU 75 110 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-A6JU 75 110 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 50 No External TCGA-CV-A6JY 52 94 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-A6JY 52 94 Treatment Radiation Therapy Radiation 2 complete response Regional Site 30 56 No External gy TCGA-CV-A6K1 44 85 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-CV-A6K2 53 92 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 30 60 No External gy TCGA-D6-6515 65 71 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 5 2000 No External Beam cgy TCGA-D6-6517 194 257 Treatment Chemotherapy Methotrexate 8 8 mg Progression IV No 62.8 mg TCGA-D6-6517 270 331 Treatment Radiation Therapy Radiation 1 Palliative Distant Site 2000 No External Beam cgy TCGA-D6-6823 84 97 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 32 6200 No External Beam cgy TCGA-D6-6827 57 67 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 8 4800 No Implants cgy TCGA-D6-A6EK 39 105 Treatment Chemotherapy Cisplatin partial response No No TCGA-D6-A6EK 39 105 Treatment Radiation Therapy Radiation 1 partial response Primary Tumor Field 35 70 No External gy TCGA-D6-A6EM 51 94 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 66 No External gy TCGA-D6-A6EN 83 125 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-D6-A6EO 73 119 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 66 No External gy TCGA-D6-A6EQ 51 92 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-D6-A6ES 88 132 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-D6-A74Q 44 88 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 66 No External gy TCGA-DQ-5624 36 63 Treatment Chemotherapy Cisplatin 2 80 mg/m2 1 Adjuvant IV No 347 mg TCGA-DQ-5624 37 86 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 5000 No External Beam cgy TCGA-DQ-5629 52 98 Treatment Chemotherapy Carboplatin 07 1 Adjuvant IV No 233 mg TCGA-DQ-5629 52 98 Treatment Radiation Therapy Radiation 1 Adjuvant Regional Site 1 35 7000 No External Beam cgy TCGA-DQ-5630 34 76 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 30 6000 No External Beam cgy TCGA-DQ-5631 32 67 Treatment Chemotherapy Cisplatin 5 40 mg/m2 01 Adjuvant IV No 80 mg TCGA-DQ-5631 475 518 Treatment Chemotherapy Carboplatin 02 2 Palliative IV No 577 mg TCGA-DQ-5631 475 518 Treatment Chemotherapy Pemetrexed 2 2 Palliative IV No 965 mg TCGA-DQ-5631 32 71 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 6000 No External Beam cgy TCGA-DQ-5631 449 456 Treatment Radiation Therapy Radiation 2 Palliative Chest Distant Recurrence 2 5 2000 No External Beam cgy TCGA-DQ-5631 477 491 Treatment Radiation Therapy Radiation 3 Palliative Back Distant Recurrence 3 12 3600 No External Beam cgy TCGA-DQ-7588 159 215 Treatment Chemotherapy Cetuximab 1 1 Recurrence IV No TCGA-DQ-7588 379 421 Treatment Chemotherapy Docetaxel 3 152 mg 2 Palliative IV No 455 mg TCGA-DQ-7588 379 421 Treatment Chemotherapy Gossypol 3 80 mg/day 2 Palliative PO No 480 mg TCGA-DQ-7588 159 215 Treatment Chemotherapy Carboplatin 1 1 Recurrence IV No TCGA-DQ-7588 421 425 Treatment Chemotherapy Gossypol 1 20 mg/day 2 Palliative PO No 100 mg TCGA-DQ-7588 159 215 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 32 6400 No External Beam cgy TCGA-DQ-7589 9 34 Treatment Chemotherapy Carboplatin stable disease No No TCGA-DQ-7589 9 34 Treatment Chemotherapy Docetaxel stable disease No No TCGA-DQ-7589 9 34 Treatment Chemotherapy Fluorouracil stable disease No No TCGA-DQ-7589 119 154 Treatment Chemotherapy Carboplatin complete response No No TCGA-DQ-7589 119 154 Treatment Chemotherapy Paclitaxel complete response No No TCGA-DQ-7589 119 164 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 66 No External gy TCGA-DQ-7590 45 87 Treatment Chemotherapy Carboplatin complete response No No TCGA-DQ-7590 45 87 Treatment Chemotherapy Paclitaxel complete response No No TCGA-DQ-7590 45 91 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 70 No External gy TCGA-DQ-7591 22 69 Treatment Chemotherapy Carboplatin 1 83 mg/wk 1 Adjuvant IV No 664 mg TCGA-DQ-7591 22 69 Treatment Chemotherapy Paclitaxel 1 56 mg/wk 1 Adjuvant IV No 448 mg TCGA-DQ-7591 22 70 Treatment Radiation Therapy Radiation 1 Adjuvant Concurrent Chemoradiation As Definitive Treatment Primary Tumor Field 1 35 7000 No External Beam cgy TCGA-DQ-7592 52 94 Treatment Chemotherapy Cisplatin 1 65 mg/wk 1 Adjuvant IV No 455 mg TCGA-DQ-7592 52 104 Treatment Radiation Therapy Radiation 1 Adjuvant Primary Tumor Field 1 6600 No External Beam cgy TCGA-DQ-7593 25 67 Treatment Chemotherapy Carboplatin complete response No No TCGA-DQ-7593 25 67 Treatment Chemotherapy Paclitaxel complete response No No TCGA-DQ-7593 25 82 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 70 No External gy TCGA-DQ-7594 12 53 Treatment Chemotherapy Paclitaxel complete response No No TCGA-DQ-7594 12 53 Treatment Chemotherapy Carboplatin complete response No No TCGA-DQ-7594 12 61 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 70 No External gy TCGA-DQ-7595 34 62 Treatment Chemotherapy Cisplatin complete response No No TCGA-DQ-7595 34 85 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 70 No External gy TCGA-DQ-7596 13 60 Treatment Chemotherapy Cetuximab partial response No No TCGA-DQ-7596 203 266 Treatment Chemotherapy Pemetrexed complete response No No TCGA-DQ-7596 203 266 Treatment Chemotherapy Carboplatin complete response No No TCGA-DQ-7596 19 69 Treatment Radiation Therapy Radiation 1 partial response Primary Tumor Field 35 70 No External gy TCGA-F7-7848 92 117 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 18 36 No External gy TCGA-F7-7848 142 162 Treatment Radiation Therapy Radiation 2 complete response Regional Site 14 28 No External gy TCGA-F7-A50G 43 72 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 40 80 No External gy TCGA-F7-A50J 70 114 Treatment Chemotherapy Cisplatin complete response No No TCGA-F7-A50J 70 114 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 66 No External gy TCGA-F7-A61S 20 73 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 2 98 No External gy TCGA-F7-A61S 230 255 Treatment Radiation Therapy Radiation 2 stable disease Regional Site 1 38 No External gy TCGA-F7-A623 19 67 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 23 46 No External gy TCGA-F7-A624 77 148 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 66 No External gy TCGA-H7-7774 424 454 Treatment Radiation Therapy Radiation 1 No TCGA-H7-8501 76 137 Treatment Chemotherapy complete response No TCGA-H7-8501 76 137 Treatment Radiation Therapy Radiation 1 complete response No TCGA-H7-8502 77 108 Treatment Chemotherapy No TCGA-H7-8502 77 108 Treatment Radiation Therapy Radiation 1 No TCGA-H7-A6C4 74 Treatment Chemotherapy Cisplatin complete response No TCGA-H7-A6C4 74 113 Treatment Radiation Therapy Radiation 1 complete response 63 No External gy TCGA-H7-A6C5 65 112 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-H7-A76A 62 101 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 63 No External gy TCGA-H7-A76A 62 101 Treatment Radiation Therapy Radiation 2 complete response Regional Site 60 No External gy TCGA-H7-A76A 62 101 Treatment Radiation Therapy Radiation 3 complete response Regional Site 51 No External TCGA-HD-7229 35 85 Treatment Chemotherapy Carboplatin No No TCGA-HD-7229 35 85 Treatment Chemotherapy Paclitaxel No No TCGA-HD-7229 35 85 Treatment Chemotherapy Cetuximab No No TCGA-HD-7229 187 187 Treatment Chemotherapy Cisplatin clinical progressive disease No No TCGA-HD-7229 187 187 Treatment Chemotherapy Docetaxel clinical progressive disease No No TCGA-HD-7229 187 187 Treatment Chemotherapy Fluorouracil clinical progressive disease No No TCGA-HD-7229 35 85 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 35 7000 No External cgy TCGA-HD-7753 71 85 Treatment Chemotherapy Cetuximab complete response No No TCGA-HD-7753 68 126 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 6630 No External cgy TCGA-HD-7831 72 116 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-HD-7832 126 172 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field No External TCGA-HD-8224 90 147 Treatment Chemotherapy Cetuximab clinical progressive disease No No TCGA-HD-8224 97 147 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 33 6600 No External cgy TCGA-HD-8314 79 121 Treatment Chemotherapy Cisplatin complete response No No TCGA-HD-8314 79 114 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-HL-7533 24 87 Treatment Chemotherapy Cisplatin complete response No No TCGA-HL-7533 24 87 Treatment Chemotherapy Docetaxel complete response No No TCGA-HL-7533 24 87 Treatment Chemotherapy Capecitabine complete response No No TCGA-IQ-7630 102 147 Treatment Chemotherapy Docetaxel complete response No No TCGA-IQ-7630 102 147 Treatment Targeted Molecular Therapy Cetuximab complete response No No TCGA-IQ-7630 102 147 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-IQ-7632 73 114 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-IQ-A61E 96 138 Treatment Chemotherapy Cisplatin complete response No No TCGA-IQ-A61E 103 142 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 60 No External gy TCGA-IQ-A61G 130 168 Treatment Chemotherapy Cisplatin clinical progressive disease No No TCGA-IQ-A61G 131 168 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 30 60 No External gy TCGA-IQ-A61J 64 99 Treatment Chemotherapy Cisplatin complete response No No TCGA-IQ-A61J 62 101 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 60 No External gy TCGA-IQ-A61K 108 108 Treatment Chemotherapy Cisplatin No No TCGA-IQ-A61K 112 138 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 44 No External gy TCGA-IQ-A61L 262 Treatment Chemotherapy Cisplatin Yes No TCGA-IQ-A61L 262 Treatment Chemotherapy Cetuximab Yes No TCGA-IQ-A61L 50 85 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 9 18 No External gy TCGA-IQ-A61L 254 262 Treatment Radiation Therapy Radiation 2 radiographic progressive disease Local Recurrence 4 8 No External gy TCGA-IQ-A61O 69 111 Treatment Chemotherapy Cisplatin complete response No No TCGA-IQ-A61O 69 127 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 66 No External gy TCGA-IQ-A6SG 59 111 Treatment Radiation Therapy Radiation 1 Regional Site 30 60 No External gy TCGA-IQ-A6SH 50 95 Treatment Radiation Therapy Radiation 1 Regional Site 30 60 No External gy TCGA-KU-A66S 59 119 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 38 6840 No External cgy TCGA-KU-A66T 121 166 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 30 5400 No External cgy TCGA-KU-A6H7 65 100 Treatment Chemotherapy Cisplatin complete response No No TCGA-KU-A6H7 65 115 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6660 No External cgy TCGA-KU-A6H7 65 115 Treatment Radiation Therapy Radiation 2 complete response Regional Site 33 6660 No External cgy TCGA-KU-A6H7 65 115 Treatment Radiation Therapy Radiation 3 complete response Regional Site 33 5610 No External cgy TCGA-KU-A6H7 65 115 Treatment Radiation Therapy Radiation 4 complete response Regional Site 33 5280 No External cgy TCGA-KU-A6H8 122 174 Treatment Immunotherapy Cetuximab clinical progressive disease No No TCGA-KU-A6H8 210 Treatment Chemotherapy Paclitaxel Yes No TCGA-KU-A6H8 210 Treatment Chemotherapy Carboplatin Yes No TCGA-KU-A6H8 116 172 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 36 7100 No External cgy TCGA-KU-A6H8 116 172 Treatment Radiation Therapy Radiation 2 radiographic progressive disease Regional Site 36 5240 No External cgy TCGA-KU-A6H8 116 172 Treatment Radiation Therapy Radiation 3 radiographic progressive disease Regional Site 36 5860 No External cgy TCGA-KU-A6H8 116 172 Treatment Radiation Therapy Radiation 4 radiographic progressive disease Regional Site 36 5550 No External cgy TCGA-MT-A51W 70 100 Treatment Radiation Therapy Radiation 1 stable disease Primary Tumor Field No External TCGA-MT-A67G 72 112 Treatment Chemotherapy Cisplatin No No TCGA-MT-A67G 50 105 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 7 6000 No External cgy TCGA-MZ-A5BI 41 70 Treatment Chemotherapy Cisplatin complete response No No TCGA-MZ-A5BI 40 86 Treatment Radiation Therapy Radiation 1 complete response Regional Site 33 69.96 No External gy TCGA-MZ-A5BI 40 86 Treatment Radiation Therapy Radiation 2 complete response Primary Tumor Field 33 69.96 No External gy TCGA-MZ-A6I9 57 99 Treatment Chemotherapy Cisplatin complete response No No TCGA-MZ-A6I9 365 421 Treatment Targeted Molecular Therapy Rigosertib clinical progressive disease No Yes TCGA-MZ-A6I9 449 449 Treatment Chemotherapy Carboplatin clinical progressive disease No No TCGA-MZ-A6I9 449 449 Treatment Chemotherapy Docetaxel clinical progressive disease No No TCGA-MZ-A6I9 57 102 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 69.96 No External gy TCGA-MZ-A6I9 57 102 Treatment Radiation Therapy Radiation 2 complete response Regional Site 33 69.96 No External gy TCGA-MZ-A7D7 77 119 Treatment Chemotherapy Cisplatin complete response No No TCGA-MZ-A7D7 526 Treatment Targeted Molecular Therapy Cetuximab Yes Yes TCGA-MZ-A7D7 526 Treatment Chemotherapy Eribulin Yes Yes TCGA-MZ-A7D7 77 126 Treatment Radiation Therapy Radiation 1 complete response Regional Site 33 66 No External gy TCGA-MZ-A7D7 77 126 Treatment Radiation Therapy Radiation 2 complete response Primary Tumor Field 33 66 No External gy TCGA-P3-A5Q5 69 120 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 6600 No External cgy TCGA-P3-A5Q5 69 120 Treatment Radiation Therapy Radiation 2 complete response Regional Site 6600 No External cgy TCGA-P3-A5Q6 43 104 Treatment Chemotherapy Cisplatin complete response No No TCGA-P3-A5Q6 43 104 Treatment Chemotherapy Cetuximab complete response No No TCGA-P3-A5Q6 49 98 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 4000 No External cgy TCGA-P3-A5Q6 49 98 Treatment Radiation Therapy Radiation 2 complete response Regional Site 5000 No External cgy TCGA-P3-A5QE 38 80 Treatment Radiation Therapy Radiation 1 complete response Regional Site 5400 No External cgy TCGA-P3-A5QE 38 80 Treatment Radiation Therapy Radiation 2 complete response Primary Tumor Field 6000 No External cgy TCGA-P3-A5QF 57 88 Treatment Chemotherapy Cetuximab No No TCGA-P3-A5QF 50 105 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 6660 No External cgy TCGA-P3-A5QF 50 105 Treatment Radiation Therapy Radiation 2 Regional Site 6660 No External cgy TCGA-P3-A6SW 61 122 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 6480 No External cgy TCGA-P3-A6SW 61 122 Treatment Radiation Therapy Radiation 2 complete response Regional Site 6480 No External cgy TCGA-P3-A6SX 61 91 Treatment Chemotherapy complete response No No TCGA-P3-A6SX 30 91 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 5940 No External cgy TCGA-P3-A6SX 30 91 Treatment Radiation Therapy Radiation 2 complete response Regional Site 5040 No External cgy TCGA-P3-A6T0 59 120 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 6000 No External cgy TCGA-P3-A6T2 30 91 Treatment Chemotherapy Cisplatin complete response No No TCGA-P3-A6T2 30 91 Treatment Radiation Therapy Radiation 1 complete response No External TCGA-P3-A6T3 61 92 Treatment Chemotherapy Cisplatin complete response No No TCGA-P3-A6T3 61 120 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 6640 No External cgy TCGA-P3-A6T3 61 120 Treatment Radiation Therapy Radiation 2 complete response Regional Site 6640 No External cgy TCGA-P3-A6T6 273 365 Treatment Chemotherapy Cetuximab clinical progressive disease No No TCGA-P3-A6T6 273 365 Treatment Chemotherapy Paclitaxel clinical progressive disease No No TCGA-P3-A6T6 30 61 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 6600 No External cgy TCGA-P3-A6T6 30 61 Treatment Radiation Therapy Radiation 2 complete response Regional Site 5000 No External cgy TCGA-P3-A6T7 91 122 Treatment Chemotherapy Cisplatin complete response No No TCGA-P3-A6T7 91 122 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 6600 No External cgy TCGA-P3-A6T7 91 122 Treatment Radiation Therapy Radiation 2 complete response Regional Site 5000 No External cgy TCGA-P3-A6T8 92 122 Treatment Chemotherapy Cisplatin complete response No No TCGA-P3-A6T8 92 122 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 5000 No External cgy TCGA-P3-A6T8 92 122 Treatment Radiation Therapy Radiation 2 complete response Regional Site 5000 No External cgy TCGA-QK-A652 77 77 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 31 59.3 No External gy TCGA-QK-A6IF 17 63 Treatment Chemotherapy Carboplatin complete response No No TCGA-QK-A6IF 17 63 Treatment Chemotherapy Paclitaxel complete response No No TCGA-QK-A6IF 16 63 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 70 No External gy TCGA-QK-A6IF 16 63 Treatment Radiation Therapy Radiation 2 complete response Regional Site 35 59.85 No External gy TCGA-QK-A6IF 16 63 Treatment Radiation Therapy Radiation 3 complete response Regional Site 35 53.9 No External gy TCGA-QK-A6IG 51 98 Treatment Chemotherapy Carboplatin clinical progressive disease No No TCGA-QK-A6IG 51 98 Treatment Chemotherapy Paclitaxel clinical progressive disease No No TCGA-QK-A6IG 51 98 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 33 66 No External gy TCGA-QK-A6IG 51 98 Treatment Radiation Therapy Radiation 2 radiographic progressive disease Regional Site 33 59.73 No External gy TCGA-QK-A6IG 51 98 Treatment Radiation Therapy Radiation 3 radiographic progressive disease Regional Site 33 53.79 No External gy TCGA-QK-A6IH 49 84 Treatment Chemotherapy Carboplatin clinical progressive disease No No TCGA-QK-A6IH 49 84 Treatment Chemotherapy Paclitaxel clinical progressive disease No No TCGA-QK-A6IH 49 91 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 38 56 No External gy TCGA-QK-A6IH 49 91 Treatment Radiation Therapy Radiation 2 Regional Site 38 50.96 No External gy TCGA-QK-A6IH 49 91 Treatment Radiation Therapy Radiation 3 Regional Site 38 45.92 No External gy TCGA-QK-A6II 57 99 Treatment Chemotherapy Cisplatin No No TCGA-QK-A6II 183 183 Treatment Chemotherapy Carboplatin clinical progressive disease No No TCGA-QK-A6II 183 183 Treatment Chemotherapy Paclitaxel clinical progressive disease No No TCGA-QK-A6II 183 183 Treatment Targeted Molecular Therapy Cetuximab clinical progressive disease No No TCGA-QK-A6II 57 112 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 24 66.7 No External gy TCGA-QK-A6II 57 112 Treatment Radiation Therapy Radiation 2 Regional Site 24 60.73 No External gy TCGA-QK-A6II 57 112 Treatment Radiation Therapy Radiation 3 Regional Site 24 54.76 No External gy TCGA-QK-A6VB 78 116 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-QK-A6VB 78 116 Treatment Radiation Therapy Radiation 2 complete response Regional Site 30 6000 No External cgy TCGA-QK-A6VC 49 66 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 14 28 No External gy TCGA-QK-A6VC 49 66 Treatment Radiation Therapy Radiation 2 Regional Site 14 25.5 No External gy TCGA-QK-A8Z7 105 166 Treatment Chemotherapy Carboplatin complete response No No TCGA-QK-A8Z7 105 166 Treatment Chemotherapy Paclitaxel complete response No No TCGA-QK-A8Z7 101 151 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 70.29 No External gy TCGA-QK-A8Z7 101 151 Treatment Radiation Therapy Radiation 2 complete response Regional Site 70.29 No External gy TCGA-QK-A8Z7 101 151 Treatment Radiation Therapy Radiation 3 complete response Regional Site 70.29 No External gy TCGA-QK-A8Z8 157 157 Treatment Chemotherapy Docetaxel No No TCGA-QK-A8Z8 157 157 Treatment Chemotherapy Cisplatin No No TCGA-QK-A8Z8 157 157 Treatment Chemotherapy Fluorouracil No No TCGA-QK-A8Z9 50 102 Treatment Chemotherapy Carboplatin complete response No No TCGA-QK-A8Z9 50 102 Treatment Chemotherapy Paclitaxel complete response No No TCGA-QK-A8Z9 267 302 Treatment Chemotherapy Carboplatin No No TCGA-QK-A8Z9 267 302 Treatment Chemotherapy Paclitaxel No No TCGA-QK-A8Z9 49 99 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 60.06 No External gy TCGA-QK-A8Z9 49 99 Treatment Radiation Therapy Radiation 2 complete response Regional Site 33 66 No External gy TCGA-QK-A8Z9 49 99 Treatment Radiation Therapy Radiation 3 complete response Regional Site 33 56.1 No External gy TCGA-QK-A8Z9 268 310 Treatment Radiation Therapy Radiation 4 Distant Site 28 50.4 No External gy TCGA-QK-A8ZA 71 118 Treatment Chemotherapy Cisplatin No No TCGA-QK-A8ZA 71 135 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 35 70 No External gy TCGA-QK-A8ZA 71 135 Treatment Radiation Therapy Radiation 2 Regional Site 35 63 No External gy TCGA-QK-A8ZA 71 135 Treatment Radiation Therapy Radiation 3 Regional Site 35 56 No External gy TCGA-QK-A8ZB 45 95 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 60 No External gy TCGA-QK-A8ZB 45 95 Treatment Radiation Therapy Radiation 2 complete response Regional Site 30 55.82 No External gy TCGA-QK-A8ZB 45 95 Treatment Radiation Therapy Radiation 3 complete response Regional Site 30 55.82 No External gy TCGA-QK-AA3J 56 106 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 70 No External gy TCGA-QK-AA3J 56 106 Treatment Radiation Therapy Radiation 2 complete response Regional Site 35 54 No External gy TCGA-QK-AA3J 56 106 Treatment Radiation Therapy Radiation 3 complete response Regional Site 35 54 No External gy TCGA-QK-AA3K 120 145 Treatment Chemotherapy Cisplatin No No TCGA-QK-AA3K 48 145 Treatment Radiation Therapy Radiation 1 Primary Tumor Field 30 66 No External gy TCGA-QK-AA3K 48 145 Treatment Radiation Therapy Radiation 2 Regional Site 30 60 No External gy TCGA-QK-AA3K 48 145 Treatment Radiation Therapy Radiation 3 Regional Site 30 60 No External gy TCGA-RS-A6TO 41 41 Treatment Immunotherapy Cetuximab complete response No No TCGA-RS-A6TO 48 94 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 35 7000 No External cgy TCGA-T2-A6WX 71 92 Treatment Chemotherapy Carboplatin clinical progressive disease No No TCGA-T2-A6WX 71 92 Treatment Chemotherapy Paclitaxel clinical progressive disease No No TCGA-T2-A6WX 71 92 Treatment Chemotherapy Cetuximab clinical progressive disease No No TCGA-T2-A6WX 71 128 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Primary Tumor Field 33 6996 No External cgy TCGA-T2-A6WX 71 128 Treatment Radiation Therapy Radiation 2 radiographic progressive disease Regional Site No External TCGA-T2-A6WZ 247 303 Treatment Targeted Molecular Therapy Sonolisib stable disease pi3k inhibitor No Yes TCGA-T2-A6WZ 247 303 Treatment Chemotherapy Docetaxel stable disease No Yes TCGA-T2-A6WZ 128 163 Treatment Chemotherapy Cetuximab clinical progressive disease No No TCGA-T2-A6WZ 139 170 Treatment Radiation Therapy Radiation 1 radiographic progressive disease Regional Site 6000 No External cgy TCGA-T2-A6WZ 139 170 Treatment Radiation Therapy Radiation 2 radiographic progressive disease Primary Tumor Field 6000 No External cgy TCGA-T2-A6X0 60 95 Treatment Chemotherapy Cisplatin complete response No No TCGA-T2-A6X0 63 99 Treatment Radiation Therapy Radiation 1 complete response Regional Site 66 No External gy TCGA-T2-A6X0 63 99 Treatment Radiation Therapy Radiation 2 complete response Primary Tumor Field 66 No External gy TCGA-TN-A7HI 66 117 Treatment Radiation Therapy Radiation 1 complete response 37 6600 No External cgy TCGA-TN-A7HJ 31 92 Treatment Chemotherapy Cisplatin complete response No No TCGA-TN-A7HJ 43 98 Treatment Radiation Therapy Radiation 1 complete response Regional Site 33 6600 No External cgy TCGA-TN-A7HL 35 62 Treatment Chemotherapy Cisplatin complete response No No TCGA-TN-A7HL 35 77 Treatment Radiation Therapy Radiation 1 complete response 30 6000 No External cgy TCGA-UF-A71B 212 269 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 32 6400 No External cgy TCGA-UF-A71B 212 269 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5000 No External cgy TCGA-UF-A71D 155 211 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-UF-A71D 155 203 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5000 No External cgy TCGA-UF-A71E 229 276 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-UF-A71E 229 266 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5000 No External cgy TCGA-UF-A7J9 172 222 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-UF-A7J9 172 215 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5000 No External cgy TCGA-UF-A7JA 281 347 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 34 6120 No External cgy TCGA-UF-A7JA 281 338 Treatment Radiation Therapy Radiation 2 complete response Regional Site 28 5040 No External cgy TCGA-UF-A7JC 131 173 Treatment Chemotherapy Cisplatin complete response No No TCGA-UF-A7JC 132 173 Treatment Radiation Therapy Radiation 1 complete response Regional Site 25 5000 No External cgy TCGA-UF-A7JC 132 187 Treatment Radiation Therapy Radiation 2 complete response Primary Tumor Field 33 6400 No External cgy TCGA-UF-A7JD 224 280 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-UF-A7JD 224 265 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5000 No External cgy TCGA-UF-A7JF 71 86 Treatment Chemotherapy Cisplatin complete response No No TCGA-UF-A7JF 56 125 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 33 6600 No External cgy TCGA-UF-A7JF 56 111 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5000 No External cgy TCGA-UF-A7JH 102 151 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-UF-A7JH 102 140 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5000 No External cgy TCGA-UF-A7JJ 60 102 Treatment Chemotherapy Cisplatin complete response No No TCGA-UF-A7JJ 59 107 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-UF-A7JJ 59 100 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5000 No External cgy TCGA-UF-A7JK 132 174 Treatment Chemotherapy Cisplatin complete response No No TCGA-UF-A7JK 127 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 32 6400 No External cgy TCGA-UF-A7JK 127 181 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5600 No External cgy TCGA-UF-A7JO 214 265 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 34 6120 No External cgy TCGA-UF-A7JO 214 250 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 4500 No External cgy TCGA-UF-A7JS 95 144 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 30 6000 No External cgy TCGA-UF-A7JS 95 134 Treatment Radiation Therapy Radiation 2 complete response Regional Site 25 5000 No External cgy TCGA-UF-A7JT 173 229 Treatment Chemotherapy Cisplatin complete response No No TCGA-UF-A7JT 176 229 Treatment Radiation Therapy Radiation 1 complete response Primary Tumor Field 34 6120 No External cgy TCGA-UF-A7JT 176 221 Treatment Radiation Therapy Radiation 2 complete response Regional Site 28 5040 No External cgy TCGA-UP-A6WW 61 123 Treatment Radiation Therapy Radiation 1 partial response Primary Tumor Field 33 66 No External gy |